PA-BENTLEY-SYSTEMS
15.4.2021 00:06:06 CEST | Business Wire | Press release
Bentley Systems, Incorporated (Nasdaq: BSY), the infrastructure engineering software company, today announced the acquisition of INRO Software, a global leader in multimodal transportation planning, traffic simulation, and mobility visualization software. The acquisition expands Bentley’s capabilities in the important growth area of mobility digital twins, just as countries including the U.S. are poised to make a generational investment in infrastructure, and as transportation systems must evolve faster to accommodate both urbanization and carbon reduction goals, and the transition to electric and autonomous vehicles.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210414005928/en/
INRO, based in Montreal, Quebec, Canada, has for more than 40 years contributed to the advancement of mobility simulation and modeling for metropolitan, regional, and national transport and transit operators and planning agencies. Users of its multimodal simulation offerings include some of the world’s busiest transit systems and metros, such as Transport for London, Transport for New South Wales, the Washington State Department of Transportation, the Swedish Transport Administration Trafikverket, and the public transport system of São Paulo SPTrans.
INRO’s products include Emme , a multimodal transportation planning system for urban, regional, and national transportation forecasting; Dynameq , a vehicle-based traffic simulation platform for city-wide traffic planning; and CityPhi , a mobility visualization solution providing data visualization and visual analytics of large-scale mobility and geospatial datasets.
Combining the capabilities of INRO’s advanced traffic and vehicle simulation with Bentley’s passenger and pedestrian simulation and civil design software, including CUBE, Streetlytics, LEGION, and OpenRoads, places Bentley in a very strong position to deliver comprehensive mobility digital twins of multimodal transportation systems at urban, metropolitan, regional, and national scale.
Advancing Mobility Digital Twins
Urban planners are seeking to understand the ongoing impacts—on transportation system performance, reliability, and accessibility—of the new opportunities and challenges of private and shared mobility, the propensity for cycling or walking, connected autonomous vehicles, and potential congestion charging. With respect to their traditionally circumscribed use of transportation modeling tools in isolation and only on occasion, multiple advantages are now attainable through mobility digital twins, which can be continuously updated with as-operated engineering conditions and with observed traffic data. Mobility digital twins bring these functions together so that infrastructure planning and simulations can be continuously valuable throughout engineering, construction, and operations.
The pandemic experience reinforces the resilience value of sustaining “evergreen” planning and engineering modeling and simulation to maintain fitness for purpose during unanticipated eventualities. With the priority now on “building back better,” it is increasingly recognized that the most economical way to augment infrastructure capacity, while accomplishing the needed energy transitions toward climate sustainability, is to optimize the utilization, configuration, and life extension of existing mobility assets, while adding integrated and appealing public transit options.
This requirement now sets the stage for mobility digital twins that need to be multimodal, need detailed dynamic traffic assignment and agent-based methods for veracity, and need to scale up to systemwide and regionwide—uniquely hallmarks of INRO. As the leader in infrastructure digital twins, Bentley’s iTwin platform can now bring together—with the best-validated aggregate and individual vehicle and pedestrian simulation—3D/4D continuous surveying and reality modeling, civil engineering and project delivery, and asset and network performance. Ultimately, the opportunity for digital cities is to save their constituents time in their day, while at the same time improving congestion and climate resilience, and safety.
“We are very pleased to welcome INRO to Bentley Systems,” said Robert Mankowski, senior vice president, digital cities, Bentley Systems. “Professor Michael Florian and his team led the research of advanced multimodal network modeling methods which helped establish state-of-the-art mobility simulation, and in this next generation his son Dan is leading its software future in our mobility digital twin advancement. With the addition of INRO and its world-class team, Bentley Systems can even better accelerate cities and regions in going digital to ‘build back better’!”
Dr. Michael Florian, founder of INRO, said, “Bentley is a recognized leader in transportation across the infrastructure lifecycle from planning and design to heavy civil construction and road network management. My colleagues and I are very excited to join Bentley and to help realize the vision shared by thousands of cities and urban regions throughout the world to improve their sustainability and quality of life.”
Image 1: Emme
Caption: Image produced with Emme (www.inrosoftware.com/emme ) using data from Metro (https://www.oregonmetro.gov/ )
Image 2: Dynameq
Caption: Image produced with Dynameq (www.inrosoftware.com/dynameq ) using data from SFCTA (https://www.sfcta.org/ )
Image 3: CityPhi
Caption: Image produced with CityPhi (www.inrosoftware.com/cityphi ) using data from http://www.andresmh.com/nyctaxitrips/
Image 4: INRO Products
Caption: INRO is a global leader in multimodal transportation planning, traffic simulation, and mobility visualization software
Video: Seattle synthetic travel demand model
Caption: Illustration of ~20 million activities completed over the course of a day by 3.6 million people from a synthesized travel demand model of the Seattle metropolitan region. Activities are shown as time-animated vertical extrusions of population movements colored by purpose. The heads-up display summarizes the visible population by current activity. Video prepared by INRO using CityPhi (www.inrosoftware.com/cityphi ). More information on source data, provided by PSRC, is available at https://www.psrc.org/activity-based-travel-model-soundcast .
About Bentley Systems
Bentley Systems (Nasdaq: BSY) is the infrastructure engineering software company. We provide innovative software to advance the world’s infrastructure – sustaining both the global economy and environment. Our industry-leading software solutions are used by professionals, and organizations of every size, for the design, construction, and operations of roads and bridges, rail and transit, water and wastewater, public works and utilities, buildings and campuses, and industrial facilities. Our offerings include MicroStation -based applications for modeling and simulation, ProjectWise for project delivery, AssetWise for asset and network performance, and the iTwin platform for infrastructure digital twins. Bentley Systems employs more than 4,000 colleagues and generates annualized revenues of more than $800 million in 172 countries. www.bentley.com
© 2021 Bentley, the Bentley logo, AssetWise, CUBE, INRO, Emme, Dynameq, CityPhi, iTwin, LEGION, MicroStation, OpenRoads, ProjectWise, and Streetlytics are either registered or unregistered trademarks or service marks of Bentley Systems, Incorporated or one of its direct or indirect wholly owned subsidiaries. All other brands and product names are trademarks of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210414005928/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Opzelura® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 13:30:00 CEST | Press release
If approved, Opzelura® (ruxolitinib) cream will be the first steroid-free, topical JAK treatment option in the European Union (EU) for adults with moderate atopic dermatitis (AD) for whom standard topical therapies have failedAD, the most common type of eczema which affects 230 million people globally,1 is a chronic, recurring, inflammatory and highly pruritic (itchy) skin condition that can have a significant impact on daily life2Phase 3 TRuE‑AD4 data supporting the positive CHMP opinion demonstrated that ruxolitinib cream met both co‑primary endpoints at Week 8, maintained disease control with as-needed treatment through Week 24 and was well tolerated3,4,5 Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids
Datroway® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 13:00:00 CEST | Press release
Recommendation based on TROPION-Breast02 phase 3 trial where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival If approved, Datroway has potential to be the first TROP2 directed antibody drug conjugate for patients in EU with a demonstrated overall survival benefit as first-line treatment Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use
DAYBU®(trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 12:49:00 CEST | Press release
-- European Commission decision expected in the coming months-- If approved, DAYBU®would become the first treatment for neurobehavioral symptoms of Rett syndrome in the European Union Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating
HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 11:18:00 CEST | Press release
HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi
Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 10:28:00 CEST | Press release
Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
